Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk
about
Soy-based renoprotectionThe estrogenic content of rodent diets, bedding, cages, and water bottles and its effect on bisphenol A studiesModification in the diet can induce beneficial effects against breast cancerSoy and Health Update: Evaluation of the Clinical and Epidemiologic LiteratureEquol, a Dietary Daidzein Gut Metabolite Attenuates Microglial Activation and Potentiates Neuroprotection In VitroDesigning a broad-spectrum integrative approach for cancer prevention and treatment.Soy-Based Therapeutic Baby Formulas: Testable Hypotheses Regarding the Pros and Cons.A hypothesis regarding the molecular mechanism underlying dietary soy-induced effects on seizure propensityThe effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy.Effect of soy isoflavones on the growth of human breast tumors: findings from preclinical studiesPotential Effects of Phytoestrogen Genistein in Modulating Acute Methotrexate Chemotherapy-Induced Osteoclastogenesis and Bone Damage in Rats.Update on genistein and thyroid: an overall message of safety.Anti-proliferative effect of Flos Albiziae flavonoids on the human gastric cancer SGC-7901 cell line.Rapid magnetic solid-phase extraction for the selective determination of isoflavones in soymilk using baicalin-functionalized magnetic nanoparticles.Dietary factors influence production of the soy isoflavone metabolite s-(-)equol in healthy adultsRegulation of the immune response by soybean isoflavones.Can breast cancer patients use soyafoods to help reduce risk of CHD?Health impact of childhood and adolescent soy consumption.Low dietary soy isoflavonoids increase hippocampal spine synapse density in ovariectomized rats.Daidzein, R-(+)equol and S-(-)equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the down-regulation of matrix metalloproteinase-2.Effect of Soy Isoflavones on Growth of Representative Bacterial Species from the Human Gut.Transcriptional regulation of glutamic acid decarboxylase in the male mouse amygdala by dietary phyto-oestrogens.Plasma bioavailability and changes in PBMC gene expression after treatment of ovariectomized rats with a commercial soy supplement.Nutrikinetic modeling reveals order of genistein phase II metabolites appearance in human plasma.Phase II metabolism of the soy isoflavones genistein and daidzein in humans, rats and mice: a cross-species and sex comparison.Risk assessment for peri- and post-menopausal women taking food supplements containing isolated isoflavonesSoy, Soy Foods and Their Role in Vegetarian Diets.Equol Enhances Apoptosis-inducing Activity of Genistein by Increasing Bax/Bcl-xL Expression Ratio in MCF-7 Human Breast Cancer Cells.Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ERΔ3, a dominant negative estrogen receptor α variant.Use of isoflavone supplements is associated with reduced postmenopausal breast cancer riskSoy supplementation: Impact on gene expression in different tissues of ovariectomized rats and evaluation of the rat model to predict (post)menopausal health effect
P2860
Q26751544-A89BA490-680A-431C-8012-C0BD3EE3D03CQ26824437-EEAE5157-A161-473A-866A-4C54F2411119Q26861193-0548F05F-57DF-4744-BCD4-A67C1AA58691Q28071946-0E9F93AD-DC36-4E75-AAD8-73C9F63C8D92Q29248888-89ED44EB-E8EB-4337-974C-89332608F4BDQ30736359-403BD733-C870-4396-8052-845FA1075FD8Q30835235-9C2857F4-C889-41BD-B8CB-E776A160186CQ34125778-2444BAC3-00F4-4D8A-921F-4B3478B87E6FQ34187693-28C03F11-60A5-4641-9395-24F86DAA9CA6Q34635316-1B2F790D-87E9-47F4-A270-F584E647ABF6Q36088558-AD70742C-9BE2-4D9B-A79B-4C713AFDE563Q36282389-1900D297-CCD5-4F91-9CCE-BD2BB9F1D27FQ36472059-948F53A0-3778-4325-A655-9383512E730EQ37214757-06850B18-FEB5-440C-B594-C2EAFDA84954Q37307326-A29EAACC-AC01-4C7A-8240-F8C98199E3CFQ38000980-BB39FC42-BF22-42DB-B3AF-192E211E9EDFQ38032972-5A432E05-0A46-4F86-BDD8-B7408CBEF752Q38609844-49C37C61-E855-459C-9ED6-9088C08258CCQ39034204-F595A58C-C449-4988-B961-CED3514A4736Q39169173-A6DCA8BF-374A-426A-9E80-6C84703D1EAAQ41195274-C8810D87-B7F5-419C-AC43-10ADB02FACC6Q41480570-592FB527-F43A-4344-85A1-B90DA2EF93B3Q41680668-180C5321-8CCF-4A65-B2BD-394F37A1643AQ44816736-DB39CFFC-FFC2-448C-9E11-88C7D4F67FB3Q46601560-D8B38AB4-B06B-4302-9FA1-A8A40FF05629Q47157326-571E21D0-04B7-447F-A1FE-A42F0698E717Q47230001-905A4185-4704-44E0-B87F-6177AD289E16Q47670578-1C71CB84-AFC4-4B0D-AB6C-D8657917F9BAQ53264621-080A3FA7-7B76-473A-B5BC-B038AC261847Q56672310-1C38B5EE-1626-4762-A27F-BE07CE60345BQ58697667-0A16D1C9-B9B0-48CC-95F6-FE653F943C09
P2860
Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Soy isoflavone phase II metabo ...... e effect on breast cancer risk
@ast
Soy isoflavone phase II metabo ...... e effect on breast cancer risk
@en
type
label
Soy isoflavone phase II metabo ...... e effect on breast cancer risk
@ast
Soy isoflavone phase II metabo ...... e effect on breast cancer risk
@en
prefLabel
Soy isoflavone phase II metabo ...... e effect on breast cancer risk
@ast
Soy isoflavone phase II metabo ...... e effect on breast cancer risk
@en
P2093
P2860
P356
P1476
Soy isoflavone phase II metabo ...... e effect on breast cancer risk
@en
P2093
Eileen C King
James E Heubi
Kenneth D R Setchell
Mark J Messina
Nadine M Brown
Stephanie L Lindley
Xueheng Zhao
P2860
P304
P356
10.3945/AJCN.111.019638
P407
P577
2011-09-28T00:00:00Z